Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Radiology

Background:

• Superparamagnetic iron oxide (SPIO) particles are utilized as contrast agents in magnetic resonance imaging (MRI).
• Particle size is a critical factor influencing the biodistribution and efficacy of SPIO-based contrast agents.

Purpose of the Study:

• To evaluate the effect of different superparamagnetic iron oxide (SPIO) particle sizes on liver contrast enhancement.
• To correlate particle distribution with magnetic resonance imaging (MRI) appearance and relaxation properties.

Main Methods:

• Relaxivity measurements were conducted in agarose gels.
• T1 relaxation times were measured using saturation recovery.
• Rabbits were intravenously injected with SPIO particles of varying sizes (30 nm, 300 nm, 3,500 nm) for MRI analysis and histological examination.

Main Results:

• SPIO particles significantly reduced T2 relaxation times in the liver and spleen, with smaller particles showing a greater effect.
• Small (30 nm) and medium (300 nm) SPIO particles decreased spleen T1 relaxation but did not affect liver T1.
• MRI signal intensity ratios (liver/muscle) were markedly reduced by small and medium SPIO particles, indicating enhanced liver contrast.
• Histological analysis revealed SPIO particle uptake in Kupffer cells (medium and large particles) and hepatocytes (small particles).

Conclusions:

• The liver contrast enhancement achieved with SPIO particles is closely linked to their cellular distribution.
• Widely distributed small SPIO particles, taken up by hepatocytes, exhibited the most effective liver contrast enhancement in MRI.